SciSparc

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell SciSparc and other ETFs, options, and stocks.

About SPRC

SciSparc Ltd. is a clinical stage pharmaceutical company, which focuses on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. It operates through the Drug Development and Online Sales segments. 

CEO
Oz Adler
CEOOz Adler
Employees
3
Employees3
Headquarters
Tel Aviv, Tel Aviv
HeadquartersTel Aviv, Tel Aviv
Founded
2004
Founded2004
Employees
3
Employees3

SPRC Key Statistics

Market cap
2.99M
Market cap2.99M
Price-Earnings ratio
-0.02
Price-Earnings ratio-0.02
Dividend yield
Dividend yield
Average volume
39.96K
Average volume39.96K
High today
$5.44
High today$5.44
Low today
$5.15
Low today$5.15
Open price
$5.17
Open price$5.17
Volume
27.33K
Volume27.33K
52 Week high
$80.10
52 Week high$80.10
52 Week low
$2.98
52 Week low$2.98

Stock Snapshot

The current SciSparc(SPRC) stock price is $5.23, with a market capitalization of 2.99M. The stock trades at a price-to-earnings (P/E) ratio of -0.02.

During the trading session on 2026-09-06, SciSparc(SPRC) shares reached a daily high of $5.44 and a low of $5.15. At a current price of $5.23, the stock is +1.6% higher than the low and still -3.8% under the high.

Trading volume for SciSparc(SPRC) stock has reached 27.33K, versus its average volume of 39.96K.

Over the past 52 weeks, SciSparc(SPRC) stock has traded between a high of $80.10 and a low of $2.98.

Over the past 52 weeks, SciSparc(SPRC) stock has traded between a high of $80.10 and a low of $2.98.

SPRC News

TipRanks 4d
SciSparc’s NeuroThera Advances Enrollment in SCI-210 Autism Trial

An announcement from SciSparc Ltd. ( (SPRC) ) is now available. On August 31, 2026, SciSparc reported that subsidiary NeuroThera Labs has enrolled 26 of a plan...

TipRanks 6d
SciSparc subsidiary provides update on SCI-210 trial enrollment

SciSparc (SPRC)announced that NeuroThera Labs continued advancement in participant enrollment for the clinical trial assessing NeuroThera’s SCI-210 treatment fo...

People also own

Based on the portfolios of people who own SPRC. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.